Baker Bros. Advisors »

Arcus Biosciences Incorporated shares owned by Baker Bros. Advisors

Quarter-by-quarter ownership of Arcus Biosciences Incorporated (RCUS) shares owned by Baker Bros. Advisors from 13F filings

Historical chart of Baker Bros. Advisors investment in Arcus Biosciences Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Arcus Biosciences Incorporated held by Baker Bros. Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arcus Biosciences Incorporated by Baker Bros. Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $6.4M 270k 23.83
2020-12-31 $1.9M 73k 25.97
2020-09-30 $2.0M 115k 17.14
2020-06-30 $3.0M 122k 24.74
2020-03-31 $1.7M 122k 13.88
2019-12-31 $1.2M 122k 10.10
2019-09-30 $1.1M 122k 9.10
2019-06-30 $966k 122k 7.95
2019-03-31 $1.5M 122k 12.49
2018-12-31 $1.3M 122k 10.77
2018-09-30 $1.7M 122k 13.94
2018-06-30 $1.5M 122k 12.24

More positions owned by Baker Bros. Advisors

Incyte Corporation (INCY)
BeOne Medicines Sponsored Ads (ONC)
Madrigal Pharmaceuticals (MDGL)
Insmed Incorporated Com Par $.01 (INSM)
ACADIA Pharmaceuticals (ACAD)
Celcuity (CELC)
Revolution Medicines (RVMD)
Kymera Therapeutics (KYMR)
Summit Therapeutics (SMMT)
Rhythm Pharmaceuticals (RYTM)
Kodiak Sciences (KOD)
Praxis Precision Medicines I (PRAX)
Alkermes SHS (ALKS)
Grail (GRAL)
Edgewise Therapeutics (EWTX)

View all positions for Baker Bros. Advisors

Top funds holding Arcus Biosciences Incorporated

Gilead Sciences
BlackRock
Vanguard Group
Suvretta Capital Management
Wellington Management Company
State Street Corporation
Woodline Partners
Marshall Wace
Point72 Asset Management
Siren
Balyasny Asset Management
Fisher Investments
Caption Management
Geode Capital Management
Bnp Paribas Investment Partners

View all funds holding Arcus Biosciences Incorporated